Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-26T14:28:57.691Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroleptic Malignant Syndrome (NMS): A Misnomer?

Published online by Cambridge University Press:  02 January 2018

Ashok N. Sinoh  and
James Maguire
Ashok N. Sinoh
Affiliation:
St Brigid's Hospital, Ardee Co., Louth, Ireland
James Maguire
Affiliation:
St Brigid's Hospital, Ardee Co., Louth, Ireland
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 151 , Issue 6 , December 1987 , pp. 863 - 864
Copyright
Copyright © Royal College of Psychiatrists, 1987 

References

Burke, R. E., Fahn, S., Mayeux, R., Weinberg, H., Louis, K. & Willner, J. (1981) Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington's disease. Neurology, 31, 1022–1026.Google Scholar
Chayasirisobhan, S., Cullis, P. & Veeramasuneni, R. R. (1983). Occurrence of neuroleptic malignant syndrome in a narcoleptic patient. Hospital and Community Psychiatry, 34, 548–550.Google Scholar
Destee, A., Petit, H. & Warot, M. (1981) Le syndrome malin des neuroleptiques. Nouvelle Presse Medicale, 19, 178.Google Scholar
Grant, R. (1984) Neuroleptic malignant syndrome. British Medical Journal, 288, 1690,CrossRefGoogle Scholar
Henderson, V. W. & Wooten, G. F. (1981) Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockage? Neurology, 31, 132–137.Google Scholar
Ritchie, P. (1983) Neuroleptic malignant syndrome. British Medical Journal, 287, 561.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.